Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aclarion, Inc. - Common Stock
(NQ:
ACON
)
8.180
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aclarion, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
40 Stocks Moving In Wednesday's Mid-Day Session
June 22, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 22, 2022
Via
Benzinga
Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain
June 22, 2022
Superior Clinical Outcomes for NociscanTM Proving to be Durable at Two Years
From
Aclarion Inc.
Via
AccessWire
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
Monday's session saw 84 companies set new 52-week lows.
Via
Benzinga
40 Stocks Moving In Monday's Mid-Day Session
May 09, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 03, 2022
During Friday's trading, 69 companies set new 52-week lows.
Via
Benzinga
20 Stocks Moving in Monday's Pre-Market Session
May 09, 2022
Gainers Decisionpoint Systems, Inc. (NASDAQ: DPSI) shares rose 32.3% to $8.85 in pre-market trading after declining over 4% on Friday.
Via
Benzinga
71 Biggest Movers From Yesterday
May 25, 2022
Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 05, 2022
Via
Benzinga
71 Biggest Movers From Yesterday
May 20, 2022
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 04, 2022
Via
Benzinga
81 Biggest Movers From Yesterday
May 05, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
May 04, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 04, 2022
It's time for another breakdown of all the biggest pre-market stock movers as we go over the news for Wednesday morning.
Via
InvestorPlace
27 Stocks Moving in Wednesday's Pre-Market Session
May 04, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday. Brickell Biotech, Inc. (NASDAQ: BBI) rose 29% to $0....
Via
Benzinga
20 Stocks Moving in Monday's Pre-Market Session
May 02, 2022
Gainers SoundHound AI, Inc. (NASDAQ: SOUN) rose 64.3% to $10.68 in pre-market trading after tumbling 13% on Friday. SoundHound had their IPO on Thursday. Better Therapeutics, Inc...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 29, 2022
Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 29, 2022
Via
Benzinga
Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering
April 26, 2022
SAN MATEO, CA / ACCESSWIRE / April 26, 2022 / Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON) (NASDAQ:ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy...
From
Aclarion Inc.
Via
AccessWire
Topics
Artificial Intelligence
Regulatory Compliance
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
Gainers Avadel Pharmaceuticals plc. (NASDAQ: AVDL) shares gained 36.3% to $5.74. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 25, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 25, 2022
Another day of investing awaits for traders as we start it off with a breakdown of the biggest pre-market stock movers for Monday!
Via
InvestorPlace
26 Stocks Moving in Monday's Pre-Market Session
April 25, 2022
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 88.4% to $2.30 in pre-market trading. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today